VNDA
#3265
Vanda Pharmaceuticals Inc. - Common Stock
5.2 9 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.76%
Variación mensual
+4.13%
Variación en los últimos 6 meses
-38.91%
Cambio anual
-4.34%
Cierres anteriores
5.4 4
Open
5.2 9
Mínimo
5.2 9
Máximo
5.2 9
Volumen
67
Financials
- Market Capitalization 319.85 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.36
Relación precio/flujo de caja
2.41
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3222 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | 0.00% | +9.05% | +36.16% | 336.28 M USD | ||
| 3260 |  IMRX Immuneering Corporation - Class A Common Stock | 4.99 USD | -4.22% | -5.67% | +22.00% | -11.52% | 322.84 M USD | ||
| 3294 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +35.51% | +92.22% | 311.95 M USD | ||
| 3308 |  IRD Opus Genetics, Inc. - Common Stock | 3.69 USD | -4.16% | -8.21% | +6.65% | -0.81% | 306.99 M USD |